Sysmex Inostics
Jen Swindell (Preston) serves as the Clinical Laboratory Services Manager at Sysmex Inostics since January 2014, overseeing project management, analytical work plans, and customer communication. Swindell has established efficient processes that expedite the onboarding of new project managers and has played a crucial role in the review and approval of laboratory work plans and reports. As a CLIA General Supervisor and Safety Officer, Swindell is dedicated to achieving NYS Accreditation and ensuring regulatory compliance. Prior experience includes roles as a Clinical Laboratory Technologist at Sysmex Inostics and an internship at the Maryland State Police Forensic Science Laboratory, supplemented by a Bachelor of Science degree in Genetic Engineering from Cedar Crest College.
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.